Presentation Information

[P2-10-3]Full-field Stimulus Test in RPE65-retinopathy and RPGR-retinopathy: Establishment of endpoint for ocular gene therapy

Kaoru Fujinami1,2,3,4,5,6,7,8,9,10, Yu Fujinami-Yokokawa1,3,7, Yasutaka Suzuki1, Jeffery Farmer8, Kazuki Yamazawa2, Haruka Murakami2, Satomi Inoue2, Tatsuo Matsunaga2,9, Kazushige Tsunoda10 (1.Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo, Japan, 2.Department of Medical Genetics, NHO Tokyo Medical Center, Tokyo, Japan, 3.Department of Genetics, UCL Institute of Ophthalmology, London, UK, 4.Moorfields Eye Hospital, London, UK, 5.Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan, 6.Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan, 7.Department of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan, 8.Diagnosys LLC, MA, USA, 9.Division of Hearing and Balance Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo, Japan; Medical Genetics Center, NHO Tokyo Medical Center, Tokyo, Japan, 10.Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo, Japan)

Password required to view